V M Jasonni

No ORCID on file · 5 papers in corpus
nonrandomized-trial 2005
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2005.02.003

The epidermal growth factor (EGF) and its receptor (EGFR) are involved in the control of the human endometrial growth [1]. The EGFR endometrial expression is up-regulated by estrogens [2]. The endometrial EGFR increases during the follicula…

nonrandomized-trial 1992
International Journal of Gynecology & Obstetrics ·doi:10.1016/0020-7292(92)90408-b

Twenty-four hirsute women were treated with an inversal sequential scheme of cyproterone acetate, 50 mg/d by oral route from the 1st to the 15th day of the menstrual cycle, along with 100 micrograms/24 h of 17 beta-estradiol transdermally a…

other 1991
Annals of the New York Academy of Sciences ·doi:10.1111/j.1749-6632.1991.tb37869.x

The unpredictable response of endometriosis to steroids and its recurrence after therapy, led us to hypothesize a possible further control of this pathology by factors other than steroids. The presence of estrogen, progesterone and epiderma…

other 1988
Acta Europaea fertilitatis

Danazol, an isoxazol derivate of ethinyltestosterone, was used in the treatment of thirtyone postmenopausal patients with endometrial hyperplasia at the dose of 400 mg/day for three months. A profound growth-inhibitory effect of danazol on …

other 1986
Cancer detection and prevention

The synthetic steroid Danazol is commonly used in the hormonal treatment of endometriosis; however, little is known about its effects on human endometrium. This study was performed to verify the efficacy of Danazol on the treatment of endom…